Bangkok: The Thai Food and Drug Administration (FDA) has issued a public warning regarding the dietary supplement "Vistorin," which is being marketed with claims of treating eye diseases. The FDA cautions consumers that such claims may exacerbate existing eye conditions and could potentially lead to vision loss.

According to Thai News Agency, the FDA's alert comes after receiving numerous complaints about the online sale of "Vistorin." The supplement is being promoted with promises such as curing cataracts, glaucoma, and pterygium, with suggestions that it is recommended by ophthalmologists and can restore clear vision without surgery. The product, which boasts a unique natural formula, is marketed as a solution for eliminating pterygium and pinguecula. It also displays an FDA registration number, 11-1-13958-5-0690, which the FDA has scrutinized.

The Thai FDA's investigation revealed that "Vistorin" is making false or misleading claims about its benefits and properties, leading consumers to be deceived. The product's marketing strategy includes an AI-generated image of a man in a lab coat to boost its credibility. As a result, the FDA, alongside related agencies, is taking legal action and closely monitoring the product's distribution. The agency strongly advises the public to be cautious and not fall for misleading advertisements.

The FDA further urges individuals, especially the elderly suffering from eye diseases, to avoid purchasing products claiming to cure eye-related ailments, as these may worsen conditions or result in vision impairment. The administration emphasizes the importance of seeking proper diagnosis and treatment from specialist ophthalmologists. For information on product registration, the public can visit the FDA website or contact the FDA via various platforms, including their hotline, social media, and provincial public health offices.